Navigation Links
Genomics of Cardiovascular Disease: Current Clinical Applications
Date:6/5/2008

KEYNOTE SPEAKER - Kari Stefansson, MD, DR. MED, CEO DeCODE Genetics

WASHINGTON, June 5 /PRNewswire-USNewswire/ -- The following media advisory was issued today by The Cheney Cardiovascular Institute:

Date: Thursday, June 12, 2008

Location: The George Washington University Hospital Auditorium

900 23rd Street, NW

Time: Noon - 2:50pm

Noon - 1:00pm Presentation by Dr. Kari Stefansson

Dr. Stefansson is CEO and co-founder of deCODE genetics and a former professor of neurology, neuropathology, and neuroscience at Harvard University.

The deCODE group has identified unique genomic markers for atherosclerosis, atrial fibrillation, and type II diabetes mellitus. As one of the world's leading experts on genomics, Dr. Stefansson will discuss the current clinical applications of cardiovascular personalized medicine. Key to understanding the potential of genomics, Dr. Stefansson will define single nucleotide polymorphisms (SNPs) and their role in genetic diseases. His talk will highlight the breakthroughs in cardiovascular genomics for both clinical cardiologists as well as researchers.

1:15 - 2:50pm Luncheon panel discussion -

Moderated by Timothy McCaffrey, PhD

Stephen B. Liggett, MD

Professor of Medicine and Physiology

Director, Cardiopulmonary Genomics

University of Maryland School of Medicine

Timothy McCaffrey, PhD

Professor of Biochemistry and Director, McCormick Genomics Center, The George Washington University School of Medicine

Gualberto Ruano, MD, PhD

President and CEO, Genomas, Inc.

The Richard B. and Lynne V. Cheney Cardiovascular Institute at The George Washington University was established in 2006 by a generous charitable contribution from Vice President Richard Cheney and his wife Lynne.

The mission of The Richard B. and Lynne V. Cheney Cardiovascular Institute is to promote clinical research, education, patient care and community service with the goal of accelerating the pace of scientific discovery, reducing mortality and improving the quality of life of Americans with cardiovascular disease. To achieve these goals, the Institute seeks to provide an interdisciplinary structure to integrate basic and clinical investigators, clinicians, medical educators, health policy experts and community leaders. For more information, please visit http://www.cheneycardioinstitute.com.


'/>"/>
SOURCE The Cheney Cardiovascular Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Navigenics Proposes Standards for Personal Genomics Services, Coupled With Prospective Outcomes Studies, to Safeguard Consumers
2. Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACCs 57th Annual Scientific Session
3. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
4. NIH announces new initiative in epigenomics
5. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2007 Healthcare Conference
6. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
7. NeoGenomics Announces Results for the 3rd Quarter 2007
8. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
9. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
10. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
11. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Francisco Canales, ... services in their Napa Valley office. The technique utilizes the body’s own healing ... Canales and Dr. Furnas, are part of only a select few cosmetic surgeons ...
(Date:2/5/2016)... ... ... US Sports Camps , official operators of Nike Yoga Camps, announces ... training. ChildLight Yoga Studio is centrally situated in the picturesque New England city of ... founder Lisa Flynn expresses her excitement, “We are thrilled to be partnering with US ...
(Date:2/5/2016)... ... February 05, 2016 , ... Boar’s Head Brand®, one of ... for this weekend’s Big Game. Take the stress out of your party preparation – ... guests happy at every stage of the game. , “The key to hosting a ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... CitiDent, announces that it is now welcoming orthodontist, Dr. Amanda Cheng, to ... a complete range of oral health care, including general dentistry, cosmetic treatments, periodontics, ...
(Date:2/5/2016)... ... February 05, 2016 , ... On June 9-10, Las ... continuing medical education (CME) event presented by the Association for Comprehensive Care in ... for ACCORD, whose mission is to provide education, tools, and resources to primary ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , February 5, 2016 Site ... Today, VoicePower Ltd - The Speech Recognition People, announced their latest ... to improve patient care, reduce turnaround times and to save the ... ,- VoicePower client since 2013 Challenge: --> ... --> - Six doctors ,- Wirral CCG ,- VoicePower ...
(Date:2/4/2016)... , Feb. 4, 2016  Edwards Lifesciences Corporation (NYSE: ... for structural heart disease and critical care monitoring, announced ... repurchase (ASR) agreement with Morgan Stanley & Co. LLC ... repurchase is part of the Company,s previously authorized program ... common stock.  --> ...
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, Inc. ... it has entered into a settlement agreement with ... fully resolving the SEC,s investigation into possible violations ... the terms of the settlement agreement, SciClone has ... including disgorgement, pre-judgment interest and a penalty.  This ...
Breaking Medicine Technology: